Press Releases

Press Releases

Morphic Therapeutic to Host Analyst and Investor Call on July 9, 2021

July 2, 2021
Call to discuss positive results from Phase 1 trial of MORF-057 to be presented at ECCO 2021 Virtual Congress WALTHAM, Mass., July 02, 2021 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of
Displaying 1 - 10 of 17